Fort, L.P. Seagen Inc. Transaction History

Fort, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $365,692 - $489,555	-2,565 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $113,105 - $134,837	-794 Reduced 23.64%	2,565 $436,000
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $142,644 - $170,121	-1,056 Reduced 23.92%	3,359 $530,000
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $254,531 - $353,170	1,851 Added 72.19%	4,415 $613,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $422,111 - $543,388	2,564 New	2,564 $449,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

Stay updated on Fort, L.P. with notifications on news.